25 XP   0   0   10

Mediwound Ltd
Buy, Hold or Sell?

Let's analyse Mediwound together

PenkeI guess you are interested in Mediwound Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Mediwound Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Mediwound Ltd

I send you an email if I find something interesting about Mediwound Ltd.

Quick analysis of Mediwound (30 sec.)










What can you expect buying and holding a share of Mediwound? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.14
Expected worth in 1 year
$4.77
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$0.63
Return On Investment
3.6%

For what price can you sell your share?

Current Price per Share
$17.59
Expected price per share
$13.57 - $18.75
How sure are you?
50%

1. Valuation of Mediwound (5 min.)




Live pricePrice per Share (EOD)

$17.59

Intrinsic Value Per Share

$-16.27 - $-12.55

Total Value Per Share

$-12.14 - $-8.41

2. Growth of Mediwound (5 min.)




Is Mediwound growing?

Current yearPrevious yearGrowGrow %
How rich?$39.2m$8.6m$26.4m75.3%

How much money is Mediwound making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$3.9m$2.2m135.8%
Net Profit Margin-39.2%-86.1%--

How much money comes from the company's main activities?

3. Financial Health of Mediwound (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#499 / 1010

Most Revenue
#361 / 1010

Most Profit
#280 / 1010

Most Efficient
#518 / 1010

What can you expect buying and holding a share of Mediwound? (5 min.)

Welcome investor! Mediwound's management wants to use your money to grow the business. In return you get a share of Mediwound.

What can you expect buying and holding a share of Mediwound?

First you should know what it really means to hold a share of Mediwound. And how you can make/lose money.

Speculation

The Price per Share of Mediwound is $17.59. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mediwound.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mediwound, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.14. Based on the TTM, the Book Value Change Per Share is $0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $1.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mediwound.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-1.0%-0.18-1.0%-0.52-2.9%-0.23-1.3%-0.45-2.5%
Usd Book Value Change Per Share0.663.7%0.160.9%1.005.7%0.160.9%0.110.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.663.7%0.160.9%1.005.7%0.160.9%0.110.6%
Usd Price Per Share10.17-11.20-4.68-5.25-6.20-
Price to Earnings Ratio-13.85--1.57--1.85--3.96--4.28-
Price-to-Total Gains Ratio15.51-7.96-1.54-5.89--4.70-
Price to Book Ratio2.46-3.05-3.43-1.88--0.84-
Price-to-Total Gains Ratio15.51-7.96-1.54-5.89--4.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.59
Number of shares56
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.160.16
Usd Total Gains Per Share0.160.16
Gains per Quarter (56 shares)8.818.94
Gains per Year (56 shares)35.2335.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10352503626
20706007262
3010695010798
401411300143134
501761650179170
602112000215206
702472350250242
802822700286278
903173050322314
1003523400358350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%2.018.00.010.0%4.036.00.010.0%5.040.00.011.1%
Book Value Change Per Share2.01.01.050.0%5.06.01.041.7%7.012.01.035.0%10.029.01.025.0%12.031.02.026.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.045.00.0%
Total Gains per Share2.01.01.050.0%5.06.01.041.7%7.012.01.035.0%10.029.01.025.0%12.031.02.026.7%

Fundamentals of Mediwound

About Mediwound Ltd

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Fundamental data was last updated by Penke on 2024-04-11 14:24:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Mediwound Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mediwound earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Mediwound to the Biotechnology industry mean.
  • A Net Profit Margin of -32.7% means that $-0.33 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mediwound Ltd:

  • The MRQ is -32.7%. The company is making a huge loss. -2
  • The TTM is -39.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-32.7%TTM-39.2%+6.5%
TTM-39.2%YOY-86.1%+46.9%
TTM-39.2%5Y-90.8%+51.6%
5Y-90.8%10Y-1,577.9%+1,487.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.7%-200.1%+167.4%
TTM-39.2%-216.8%+177.6%
YOY-86.1%-288.3%+202.2%
5Y-90.8%-449.1%+358.3%
10Y-1,577.9%-605.5%-972.4%
1.1.2. Return on Assets

Shows how efficient Mediwound is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mediwound to the Biotechnology industry mean.
  • -2.6% Return on Assets means that Mediwound generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mediwound Ltd:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.5%-0.2%
TTM-2.5%YOY-13.6%+11.1%
TTM-2.5%5Y-7.2%+4.7%
5Y-7.2%10Y-7.7%+0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-13.3%+10.7%
TTM-2.5%-12.8%+10.3%
YOY-13.6%-11.7%-1.9%
5Y-7.2%-13.9%+6.7%
10Y-7.7%-15.7%+8.0%
1.1.3. Return on Equity

Shows how efficient Mediwound is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mediwound to the Biotechnology industry mean.
  • -5.5% Return on Equity means Mediwound generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mediwound Ltd:

  • The MRQ is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-5.2%-0.4%
TTM-5.2%YOY-112.3%+107.1%
TTM-5.2%5Y-40.5%+35.3%
5Y-40.5%10Y-42.3%+1.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.5%-16.9%+11.4%
TTM-5.2%-16.1%+10.9%
YOY-112.3%-15.1%-97.2%
5Y-40.5%-19.3%-21.2%
10Y-42.3%-20.2%-22.1%

1.2. Operating Efficiency of Mediwound Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mediwound is operating .

  • Measures how much profit Mediwound makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mediwound to the Biotechnology industry mean.
  • An Operating Margin of -72.7% means the company generated $-0.73  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mediwound Ltd:

  • The MRQ is -72.7%. The company is operating very inefficient. -2
  • The TTM is -83.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-72.7%TTM-83.7%+11.0%
TTM-83.7%YOY-80.5%-3.2%
TTM-83.7%5Y-91.1%+7.4%
5Y-91.1%10Y-1,320.2%+1,229.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.7%-296.2%+223.5%
TTM-83.7%-232.5%+148.8%
YOY-80.5%-298.2%+217.7%
5Y-91.1%-492.1%+401.0%
10Y-1,320.2%-632.4%-687.8%
1.2.2. Operating Ratio

Measures how efficient Mediwound is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.73 means that the operating costs are $1.73 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Mediwound Ltd:

  • The MRQ is 1.727. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.837. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.727TTM1.837-0.110
TTM1.837YOY1.805+0.032
TTM1.8375Y1.910-0.073
5Y1.91010Y17.467-15.557
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7273.231-1.504
TTM1.8373.310-1.473
YOY1.8053.890-2.085
5Y1.9105.739-3.829
10Y17.4677.876+9.591

1.3. Liquidity of Mediwound Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mediwound is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.59 means the company has $4.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Mediwound Ltd:

  • The MRQ is 4.589. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.179. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.589TTM6.179-1.589
TTM6.179YOY3.277+2.902
TTM6.1795Y3.642+2.537
5Y3.64210Y7.302-3.660
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5893.890+0.699
TTM6.1794.173+2.006
YOY3.2775.344-2.067
5Y3.6426.126-2.484
10Y7.3026.448+0.854
1.3.2. Quick Ratio

Measures if Mediwound is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mediwound to the Biotechnology industry mean.
  • A Quick Ratio of 7.00 means the company can pay off $7.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mediwound Ltd:

  • The MRQ is 7.000. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.713. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.000TTM8.713-1.713
TTM8.713YOY3.359+5.354
TTM8.7135Y4.687+4.025
5Y4.68710Y10.568-5.881
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0003.514+3.486
TTM8.7133.998+4.715
YOY3.3595.380-2.021
5Y4.6876.105-1.418
10Y10.5686.404+4.164

1.4. Solvency of Mediwound Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mediwound assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mediwound to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.41 means that Mediwound assets are financed with 40.9% credit (debt) and the remaining percentage (100% - 40.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mediwound Ltd:

  • The MRQ is 0.409. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.472. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.409TTM0.472-0.063
TTM0.472YOY0.872-0.400
TTM0.4725Y0.750-0.277
5Y0.75010Y0.706+0.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4090.339+0.070
TTM0.4720.336+0.136
YOY0.8720.271+0.601
5Y0.7500.366+0.384
10Y0.7060.389+0.317
1.4.2. Debt to Equity Ratio

Measures if Mediwound is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mediwound to the Biotechnology industry mean.
  • A Debt to Equity ratio of 86.0% means that company has $0.86 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mediwound Ltd:

  • The MRQ is 0.860. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.948. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.860TTM0.948-0.088
TTM0.948YOY7.470-6.522
TTM0.9485Y3.577-2.629
5Y3.57710Y3.673-0.096
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8600.388+0.472
TTM0.9480.402+0.546
YOY7.4700.335+7.135
5Y3.5770.426+3.151
10Y3.6730.461+3.212

2. Market Valuation of Mediwound Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Mediwound generates.

  • Above 15 is considered overpriced but always compare Mediwound to the Biotechnology industry mean.
  • A PE ratio of -13.85 means the investor is paying $-13.85 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mediwound Ltd:

  • The EOD is -23.947. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.845. Based on the earnings, the company is expensive. -2
  • The TTM is -1.572. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-23.947MRQ-13.845-10.102
MRQ-13.845TTM-1.572-12.274
TTM-1.572YOY-1.849+0.278
TTM-1.5725Y-3.958+2.386
5Y-3.95810Y-4.280+0.323
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-23.947-2.264-21.683
MRQ-13.845-2.629-11.216
TTM-1.572-2.680+1.108
YOY-1.849-4.145+2.296
5Y-3.958-6.257+2.299
10Y-4.280-6.254+1.974
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mediwound Ltd:

  • The EOD is -10.567. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.110. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.071. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.567MRQ-6.110-4.458
MRQ-6.110TTM-13.071+6.961
TTM-13.071YOY-10.041-3.030
TTM-13.0715Y-5.762-7.309
5Y-5.76210Y-5.063-0.699
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.567-2.973-7.594
MRQ-6.110-3.333-2.777
TTM-13.071-3.553-9.518
YOY-10.041-5.605-4.436
5Y-5.762-8.376+2.614
10Y-5.063-8.865+3.802
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mediwound is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.46 means the investor is paying $2.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Mediwound Ltd:

  • The EOD is 4.251. Based on the equity, the company is fair priced.
  • The MRQ is 2.458. Based on the equity, the company is underpriced. +1
  • The TTM is 3.052. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.251MRQ2.458+1.793
MRQ2.458TTM3.052-0.594
TTM3.052YOY3.427-0.376
TTM3.0525Y1.883+1.169
5Y1.88310Y-0.844+2.727
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.2511.896+2.355
MRQ2.4582.115+0.343
TTM3.0522.093+0.959
YOY3.4272.884+0.543
5Y1.8833.542-1.659
10Y-0.8443.916-4.760
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Mediwound Ltd.

3.1. Institutions holding Mediwound Ltd

Institutions are holding 33.853% of the shares of Mediwound Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Point72 Asset Management, L.P.8.91070.025582150000
2023-09-30Dafna Capital Management LLC2.79470.852725765300
2023-09-30Uniplan Investment Counsel, Inc.1.62790.12515007823221.5715
2023-09-30Wells Fargo & Co1.48210.00041366422391521.215
2023-09-30Alyeska Investment Group, L.P.1.38550.0092127729-22271-14.8473
2023-12-31Sargent Investment Group, LLC1.18440.243210919471256.9806
2023-09-30Sphera Funds Management Ltd.1.17720.2104108533-2594-2.3343
2023-09-30Yelin Lapidot Holdings Management Ltd0.93440.545286145861450
2023-12-31Renaissance Technologies Corp0.60680.00095594410001.82
2023-12-31Essex Investment Management Company, LLC0.42070.077738782-14101-26.6645
2023-09-30Meitav Dash Investments Ltd0.34170.00513150200
2023-09-30BlackRock Inc0.1591014671-567-3.721
2023-09-30Advisor Group Holdings, Inc.0.06660.00016144-44-0.7111
2023-09-30PNC Financial Services Group Inc0.04590422900
2023-09-30Morgan Stanley - Brokerage Accounts0.0384035442708.2468
2023-09-30Tower Research Capital LLC0.00160.0001151-886-85.4388
2023-09-30Steward Partners Investment Advisory, LLC0.0016014300
2023-09-30Awm Investment Company Inc000-142857-100
2023-09-30UBS Group AG000-45-100
Total 21.17932.09551952584-62588-3.2%

3.2. Funds holding Mediwound Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-311290 Essex Small Cap Growth I0.270.59424889248890
2023-11-30Meitav Sky Stocks IL0.18640.16911718300
2023-11-30Meitav Sky Investments0.15530.31481431900
2023-11-30Dolphin 90/10 IL0.12470.03411150000
2024-02-29iShares Micro-Cap ETF0.11390.01671050300
2023-11-30I.B.I 70/300.0790.0401728700
2023-10-31Yelin Lapidot Equity IL0.04820.0163444544450
2024-01-31Fidelity Nasdaq Composite Index0.03960.0003365296135.7116
2023-12-31Essex Inv Mgt Micro Cap Growth0.03580.4523305-2157-39.491
2023-11-30Dolphin Flexible0.02710.3733250000
2023-10-31Yelin Lapidot Growth Equity IL0.01510.0165138813880
2023-11-30Achord 70/30 IL0.0130.3053120000
2023-11-30Dolphin Stocks IL0.00980.209990000
2023-11-30Achord 90/10 IL0.00950.100188000
2024-01-311290 VT Micro Cap K0.00870.007380300
2023-09-30Uniplan Micro Cap Portfolio0.00860.8609792506.7385
2023-11-30Dolphin75/25 IL0.00560.056751300
2023-11-30Achord 80/20 IL0.00430.0896400-337-45.7259
Total 1.15463.657106459+29239+27.5%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Mediwound Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6560.157+317%0.998-34%0.160+311%0.107+513%
Book Value Per Share--4.1383.702+12%0.913+353%1.435+188%1.812+128%
Current Ratio--4.5896.179-26%3.277+40%3.642+26%7.302-37%
Debt To Asset Ratio--0.4090.472-13%0.872-53%0.750-45%0.706-42%
Debt To Equity Ratio--0.8600.948-9%7.470-88%3.577-76%3.673-77%
Dividend Per Share----0%-0%-0%-0%
Eps---0.184-0.177-4%-0.516+181%-0.232+27%-0.448+144%
Free Cash Flow Per Share---0.416-0.423+2%-0.398-4%-0.218-48%-0.331-20%
Free Cash Flow To Equity Per Share---0.4670.173-369%0.797-159%0.129-462%0.101-562%
Gross Profit Margin--1.0001.0000%1.244-20%1.163-14%1.319-24%
Intrinsic Value_10Y_max---12.552--------
Intrinsic Value_10Y_min---16.274--------
Intrinsic Value_1Y_max---1.317--------
Intrinsic Value_1Y_min---1.470--------
Intrinsic Value_3Y_max---3.912--------
Intrinsic Value_3Y_min---4.583--------
Intrinsic Value_5Y_max---6.453--------
Intrinsic Value_5Y_min---7.853--------
Market Cap166959354.800+42%96530792.400106283534.700-9%44397520.300+117%49869496.880+94%58862640.558+64%
Net Profit Margin---0.327-0.392+20%-0.861+164%-0.908+178%-15.779+4732%
Operating Margin---0.727-0.837+15%-0.805+11%-0.911+25%-13.202+1716%
Operating Ratio--1.7271.837-6%1.805-4%1.910-10%17.467-90%
Pb Ratio4.251+42%2.4583.052-19%3.427-28%1.883+31%-0.844+134%
Pe Ratio-23.947-73%-13.845-1.572-89%-1.849-87%-3.958-71%-4.280-69%
Price Per Share17.590+42%10.17011.198-9%4.678+117%5.254+94%6.201+64%
Price To Free Cash Flow Ratio-10.567-73%-6.110-13.071+114%-10.041+64%-5.762-6%-5.063-17%
Price To Total Gains Ratio26.834+42%15.5147.960+95%1.538+909%5.888+163%-4.698+130%
Quick Ratio--7.0008.713-20%3.359+108%4.687+49%10.568-34%
Return On Assets---0.026-0.025-6%-0.136+418%-0.072+173%-0.077+195%
Return On Equity---0.055-0.052-7%-1.123+1936%-0.405+633%-0.423+667%
Total Gains Per Share--0.6560.157+317%0.998-34%0.160+311%0.107+513%
Usd Book Value--39272000.00035137750.000+12%8666500.000+353%13623250.000+188%17196100.000+128%
Usd Book Value Change Per Share--0.6560.157+317%0.998-34%0.160+311%0.107+513%
Usd Book Value Per Share--4.1383.702+12%0.913+353%1.435+188%1.812+128%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.184-0.177-4%-0.516+181%-0.232+27%-0.448+144%
Usd Free Cash Flow---3949886.000-4013721.500+2%-3779750.000-4%-2072794.300-48%-3144397.150-20%
Usd Free Cash Flow Per Share---0.416-0.423+2%-0.398-4%-0.218-48%-0.331-20%
Usd Free Cash Flow To Equity Per Share---0.4670.173-369%0.797-159%0.129-462%0.101-562%
Usd Market Cap166959354.800+42%96530792.400106283534.700-9%44397520.300+117%49869496.880+94%58862640.558+64%
Usd Price Per Share17.590+42%10.17011.198-9%4.678+117%5.254+94%6.201+64%
Usd Profit---1743000.000-1679000.000-4%-3958750.000+127%-2017150.000+16%-3084850.000+77%
Usd Revenue--5338000.0004671500.000+14%4669250.000+14%5733900.000-7%3074825.000+74%
Usd Total Gains Per Share--0.6560.157+317%0.998-34%0.160+311%0.107+513%
 EOD+6 -2MRQTTM+20 -13YOY+22 -125Y+25 -910Y+24 -10

4.2. Fundamental Score

Let's check the fundamental score of Mediwound Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-23.947
Price to Book Ratio (EOD)Between0-14.251
Net Profit Margin (MRQ)Greater than0-0.327
Operating Margin (MRQ)Greater than0-0.727
Quick Ratio (MRQ)Greater than17.000
Current Ratio (MRQ)Greater than14.589
Debt to Asset Ratio (MRQ)Less than10.409
Debt to Equity Ratio (MRQ)Less than10.860
Return on Equity (MRQ)Greater than0.15-0.055
Return on Assets (MRQ)Greater than0.05-0.026
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Mediwound Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.297
Ma 20Greater thanMa 5015.759
Ma 50Greater thanMa 10015.217
Ma 100Greater thanMa 20013.306
OpenGreater thanClose16.260
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets66,459
Total Liabilities27,187
Total Stockholder Equity31,595
 As reported
Total Liabilities 27,187
Total Stockholder Equity+ 31,595
Total Assets = 66,459

Assets

Total Assets66,459
Total Current Assets49,695
Long-term Assets16,764
Total Current Assets
Cash And Cash Equivalents 12,033
Short-term Investments 29,675
Net Receivables 4,419
Inventory 2,846
Other Current Assets 722
Total Current Assets  (as reported)49,695
Total Current Assets  (calculated)49,695
+/-0
Long-term Assets
Property Plant Equipment 15,926
Intangible Assets 165
Long-term Assets Other 183
Long-term Assets  (as reported)16,764
Long-term Assets  (calculated)16,274
+/- 490

Liabilities & Shareholders' Equity

Total Current Liabilities10,829
Long-term Liabilities16,358
Total Stockholder Equity31,595
Total Current Liabilities
Short-term Debt 361
Accounts payable 5,528
Other Current Liabilities 4,916
Total Current Liabilities  (as reported)10,829
Total Current Liabilities  (calculated)10,805
+/- 24
Long-term Liabilities
Capital Lease Obligations 6,350
Long-term Liabilities Other 9,933
Long-term Liabilities  (as reported)16,358
Long-term Liabilities  (calculated)16,283
+/- 75
Total Stockholder Equity
Common Stock184
Retained Earnings -174,822
Accumulated Other Comprehensive Income -18
Other Stockholders Equity 206,251
Total Stockholder Equity (as reported)31,595
Total Stockholder Equity (calculated)31,595
+/-0
Other
Capital Stock184
Cash and Short Term Investments 41,708
Common Stock Shares Outstanding 9,220
Current Deferred Revenue24
Liabilities and Stockholders Equity 66,459
Net Debt -5,322
Net Invested Capital 31,595
Net Working Capital 38,866
Property Plant and Equipment Gross 23,062
Short Long Term Debt Total 6,711



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
25,438
0
24,363
16,986
14,826
86,488
80,201
75,597
71,121
65,636
61,314
55,813
52,523
48,684
44,345
39,921
35,764
31,626
27,320
49,011
44,135
40,800
36,743
34,757
35,276
34,792
49,875
44,314
40,590
37,798
34,616
35,321
31,070
29,694
26,204
23,166
19,744
26,367
21,106
28,585
68,666
68,666
64,366
67,017
66,459
66,45967,01764,36668,66668,66628,58521,10626,36719,74423,16626,20429,69431,07035,32134,61637,79840,59044,31449,87534,79235,27634,75736,74340,80044,13549,01127,32031,62635,76439,92144,34548,68452,52355,81361,31465,63671,12175,59780,20186,48814,82616,98624,363025,438
   > Total Current Assets 
0
0
3,297
14,387
12,065
83,834
77,453
72,875
68,497
63,505
59,091
53,596
50,395
46,408
42,093
37,625
33,612
29,496
25,135
46,468
41,520
38,205
34,099
32,184
32,713
29,727
44,896
39,431
35,622
32,855
29,808
30,323
26,193
24,906
21,520
18,671
14,952
21,956
16,809
24,448
63,271
63,271
58,053
53,250
49,695
49,69553,25058,05363,27163,27124,44816,80921,95614,95218,67121,52024,90626,19330,32329,80832,85535,62239,43144,89629,72732,71332,18434,09938,20541,52046,46825,13529,49633,61237,62542,09346,40850,39553,59659,09163,50568,49772,87577,45383,83412,06514,3873,29700
       Cash And Cash Equivalents 
337
0
403
12,174
7,053
80,570
20,816
18,933
25,422
17,099
13,777
24,550
42,502
9,026
10,594
5,182
28,866
4,151
2,775
25,402
36,069
9,991
5,659
4,867
6,716
7,134
24,667
7,743
7,242
7,981
12,612
10,741
17,376
0
16,993
0
11,046
0
7,729
17,592
51,020
51,020
51,122
9,279
12,033
12,0339,27951,12251,02051,02017,5927,729011,046016,993017,37610,74112,6127,9817,2427,74324,6677,1346,7164,8675,6599,99136,06925,4022,7754,15128,8665,18210,5949,02642,50224,55013,77717,09925,42218,93320,81680,5707,05312,1744030337
       Short-term Investments 
0
0
0
0
2,500
0
52,762
50,074
39,431
42,328
41,457
25,398
3,266
32,565
27,166
28,774
1,163
21,078
18,147
15,191
0
22,912
21,345
20,871
16,917
14,211
13,870
25,113
22,036
19,330
11,770
14,282
4,024
0
0
0
0
0
2,509
2,521
6,184
6,184
31,956
36,244
29,675
29,67536,24431,9566,1846,1842,5212,509000004,02414,28211,77019,33022,03625,11313,87014,21116,91720,87121,34522,912015,19118,14721,0781,16328,77427,16632,5653,26625,39841,45742,32839,43150,07452,76202,5000000
       Net Receivables 
0
0
2,426
2,213
2,004
2,455
2,564
2,356
2,223
2,081
2,084
2,009
2,912
3,283
3,173
2,606
2,739
3,276
3,089
4,238
3,565
3,282
5,224
4,704
7,400
6,738
4,649
5,156
4,551
3,540
3,492
3,495
3,229
5,574
2,948
3,553
2,706
3,200
4,412
4,976
3,531
3,531
3,818
4,071
4,419
4,4194,0713,8183,5313,5314,9764,4123,2002,7063,5532,9485,5743,2293,4953,4923,5404,5515,1564,6496,7387,4004,7045,2243,2823,5654,2383,0893,2762,7392,6063,1733,2832,9122,0092,0842,0812,2232,3562,5642,4552,0042,2132,42600
       Inventory 
862
0
468
0
1,000
809
1,311
1,512
1,421
1,997
1,773
1,639
1,715
1,534
1,160
1,063
844
991
1,124
1,637
1,886
2,020
1,871
1,742
1,680
1,472
1,535
1,419
1,613
2,004
1,934
1,805
1,380
1,470
1,397
1,252
1,200
1,920
1,991
1,880
2,536
2,536
3,113
3,656
2,846
2,8463,6563,1132,5362,5361,8801,9911,9201,2001,2521,3971,4701,3801,8051,9342,0041,6131,4191,5351,4721,6801,7421,8712,0201,8861,6371,1249918441,0631,1601,5341,7151,6391,7731,9971,4211,5121,3118091,00004680862
   > Long-term Assets 
0
0
21,066
2,599
2,761
2,654
2,748
2,722
2,624
2,131
2,223
2,217
2,128
2,276
2,252
2,296
2,152
2,130
2,185
2,543
2,615
2,595
2,644
2,573
2,563
5,065
4,979
4,883
4,968
4,943
4,808
4,998
4,877
4,788
4,684
4,495
4,792
4,411
4,297
4,137
5,395
5,395
6,313
13,767
16,764
16,76413,7676,3135,3955,3954,1374,2974,4114,7924,4954,6844,7884,8774,9984,8084,9434,9684,8834,9795,0652,5632,5732,6442,5952,6152,5432,1852,1302,1522,2962,2522,2762,1282,2172,2232,1312,6242,7222,7482,6542,7612,59921,06600
       Property Plant Equipment 
1,274
0
1,197
1,201
1,136
1,110
1,204
1,209
1,088
1,050
1,066
1,096
1,040
1,267
1,270
1,362
1,276
1,357
1,425
1,834
1,924
1,949
2,051
2,004
2,020
4,569
4,498
4,423
4,533
4,530
4,412
4,618
4,514
4,441
4,354
4,181
4,026
3,900
3,803
3,659
4,875
4,875
5,838
13,102
15,926
15,92613,1025,8384,8754,8753,6593,8033,9004,0264,1814,3544,4414,5144,6184,4124,5304,5334,4234,4984,5692,0202,0042,0511,9491,9241,8341,4251,3571,2761,3621,2701,2671,0401,0961,0661,0501,0881,2091,2041,1101,1361,2011,19701,274
       Intangible Assets 
5,093
0
4,744
914
1,004
987
966
950
951
930
908
887
896
874
853
831
773
729
685
649
635
590
528
512
495
479
462
446
429
413
396
8,237
363
0
0
0
297
0
264
248
215
0
198
0
165
1650198021524826402970003638,2373964134294464624794955125285906356496857297738318538748968879089309519509669871,0049144,74405,093
       Long-term Assets Other 
0
0
15,125
484
621
557
578
568
585
151
249
234
192
135
129
103
103
44
75
60
56
54
-5
57
48
17
19
14
6
4,943
0
-7,857
0
347
330
314
469
230
-4,067
-3,907
-5,090
305
-6,036
483
183
183483-6,036305-5,090-3,907-4,0672304693143303470-7,85704,94361419174857-5545660754410310312913519223424915158556857855762148415,12500
> Total Liabilities 
9,804
0
15,692
36,296
34,630
29,178
27,773
26,906
28,250
28,487
27,661
25,263
29,053
28,120
30,376
31,049
27,994
27,845
27,676
37,226
34,515
35,772
35,713
36,535
26,304
29,651
31,696
25,996
25,421
24,909
24,484
26,704
23,798
24,878
24,086
23,987
24,326
24,422
23,341
26,929
35,366
35,366
29,437
33,967
27,187
27,18733,96729,43735,36635,36626,92923,34124,42224,32623,98724,08624,87823,79826,70424,48424,90925,42125,99631,69629,65126,30436,53535,71335,77234,51537,22627,67627,84527,99431,04930,37628,12029,05325,26327,66128,48728,25026,90627,77329,17834,63036,29615,69209,804
   > Total Current Liabilities 
3,364
0
8,959
1,638
2,023
5,346
3,103
2,799
3,897
3,955
3,888
3,374
5,206
4,959
5,395
4,981
5,380
5,087
4,236
12,979
5,433
6,294
5,666
5,888
4,897
7,452
10,858
10,811
10,373
10,683
9,784
11,630
8,266
10,314
9,661
9,961
10,721
11,250
10,416
9,012
9,264
9,264
8,309
8,441
10,829
10,8298,4418,3099,2649,2649,01210,41611,25010,7219,9619,66110,3148,26611,6309,78410,68310,37310,81110,8587,4524,8975,8885,6666,2945,43312,9794,2365,0875,3804,9815,3954,9595,2063,3743,8883,9553,8972,7993,1035,3462,0231,6388,95903,364
       Short-term Debt 
0
0
6,769
0
0
0
0
0
2,683
0
0
0
4,083
0
0
0
2,060
0
0
0
2,182
0
0
0
0
2,018
0
0
5,488
0
0
0
3,062
0
0
0
3,077
0
2,479
2,461
532
0
0
0
361
3610005322,4612,47903,0770003,0620005,488002,01800002,1820002,0600004,0830002,683000006,76900
       Short Long Term Debt 
0
0
0
0
0
0
0
0
2,683
0
0
0
4,083
0
0
0
2,060
0
0
0
2,182
0
0
0
0
2,018
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,01800002,1820002,0600004,0830002,68300000000
       Accounts payable 
775
0
791
576
1,180
823
1,264
797
1,214
1,096
997
1,253
1,123
1,815
1,571
1,031
1,456
2,732
2,121
3,289
3,251
3,380
3,327
3,563
2,715
2,996
4,073
2,863
4,067
3,423
2,423
3,155
2,992
3,258
4,060
3,710
4,693
5,623
4,877
3,565
3,403
3,403
3,531
3,680
5,528
5,5283,6803,5313,4033,4033,5654,8775,6234,6933,7104,0603,2582,9923,1552,4233,4234,0672,8634,0732,9962,7153,5633,3273,3803,2513,2892,1212,7321,4561,0311,5711,8151,1231,2539971,0961,2147971,2648231,1805767910775
       Other Current Liabilities 
1,034
0
153
1,062
843
4,523
1,839
2,002
2,683
2,859
2,891
2,121
3,992
3,144
3,824
3,950
3,802
2,355
2,115
9,690
2,051
2,914
2,339
2,325
1,984
4,456
6,785
7,948
569
7,260
7,361
8,475
1,750
7,056
5,601
6,251
2,408
5,627
5,539
5,447
5,861
5,861
4,778
4,761
4,916
4,9164,7614,7785,8615,8615,4475,5395,6272,4086,2515,6017,0561,7508,4757,3617,2605697,9486,7854,4561,9842,3252,3392,9142,0519,6902,1152,3553,8023,9503,8243,1443,9922,1212,8912,8592,6832,0021,8394,5238431,06215301,034
   > Long-term Liabilities 
0
0
6,733
34,658
32,607
23,832
24,670
24,107
24,353
24,532
23,773
21,889
23,847
23,161
24,981
26,068
22,614
22,758
23,440
24,247
29,082
29,478
30,047
30,647
21,407
22,199
20,838
15,185
15,048
14,226
14,700
15,074
15,532
14,564
14,425
14,026
13,605
13,172
12,925
17,917
26,102
26,102
21,128
25,526
16,358
16,35825,52621,12826,10226,10217,91712,92513,17213,60514,02614,42514,56415,53215,07414,70014,22615,04815,18520,83822,19921,40730,64730,04729,47829,08224,24723,44022,75822,61426,06824,98123,16123,84721,88923,77324,53224,35324,10724,67023,83232,60734,6586,73300
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,043
2,022
2,015
2,006
1,905
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,9052,0062,0152,0222,0430000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
-6,769
0
0
0
0
0
-2,683
0
0
0
-4,083
0
0
0
-2,060
0
0
0
-2,182
0
0
0
0
25
2,022
2,015
-3,482
1,905
1,866
1,942
-1,321
1,590
1,604
1,483
-1,686
1,239
-1,426
-1,509
314
743
677
5,935
5,989
5,9895,935677743314-1,509-1,4261,239-1,6861,4831,6041,590-1,3211,9421,8661,905-3,4822,0152,022250000-2,182000-2,060000-4,083000-2,68300000-6,76900
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,683
11,331
11,720
11,664
11,039
11,379
11,565
12,265
12,008
12,136
11,910
11,807
11,539
11,492
11,527
10,233
10,240
10,335
10,254
9,933
9,93310,25410,33510,24010,23311,52711,49211,53911,80711,91012,13612,00812,26511,56511,37911,03911,66411,72011,33112,6830000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
1,023
0
0
0
1,023
0
0
0
1,023
0
0
0
988
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000009880001,0230001,0230001,02300000000
> Total Stockholder Equity
15,634
0
8,671
-19,310
-19,804
57,310
52,428
48,691
42,871
37,149
33,653
30,550
23,470
20,564
13,969
8,872
7,770
3,781
-356
11,785
9,620
5,028
1,030
-1,778
8,972
5,141
18,179
18,318
15,169
12,889
10,132
8,617
7,272
4,816
2,118
-821
-4,582
1,945
-2,235
1,656
33,300
33,300
34,929
33,050
31,595
31,59533,05034,92933,30033,3001,656-2,2351,945-4,582-8212,1184,8167,2728,61710,13212,88915,16918,31818,1795,1418,972-1,7781,0305,0289,62011,785-3563,7817,7708,87213,96920,56423,47030,55033,65337,14942,87148,69152,42857,310-19,804-19,3108,671015,634
   Common Stock
9
0
9
11
11
61
59
59
59
59
60
60
60
60
60
60
60
60
60
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
93
93
115
33,300
33,300
184
33,050
184
18433,05018433,30033,300115939375757575757575757575757575757575757560606060606060606059595959611111909
   Retained Earnings Total Equity000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-8
-32
-42
-25
9
-18
-17
-17
-17
-16
-22
-19
-20
-9
-12
-26
-28
-38
-48
-30
-29
-25
-21
-23
-16
-17
-18
-32
-28
-40
0
-32
0
-19
0
3
15
-5
0
-14
0
-18
-180-140-51530-190-320-40-28-32-18-17-16-23-21-25-29-30-48-38-28-26-12-9-20-19-22-16-17-17-17-189-25-42-32-8000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,637
139,912
140,236
140,568
140,871
141,044
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000141,044140,871140,568140,236139,912139,637000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000-34,600-34,6000000
   Other Stockholders Equity 
0
0
48,196
27,387
27,629
105,452
106,570
107,816
109,117
109,804
110,439
111,102
111,801
112,675
113,588
114,203
114,979
115,307
115,646
138,778
138,992
139,210
139,359
139,494
139,637
139,912
140,236
18,334
140,871
12,907
10,164
8,645
142,193
4,816
143,077
-821
143,869
1,945
154,119
1,656
0
0
205,642
0
206,251
206,2510205,642001,656154,1191,945143,869-821143,0774,816142,1938,64510,16412,907140,87118,334140,236139,912139,637139,494139,359139,210138,992138,778115,646115,307114,979114,203113,588112,675111,801111,102110,439109,804109,117107,816106,570105,45227,62927,38748,19600



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue18,686
Cost of Revenue-15,739
Gross Profit2,9472,947
 
Operating Income (+$)
Gross Profit2,947
Operating Expense-18,448
Operating Income-15,501-15,501
 
Operating Expense (+$)
Research Development7,071
Selling General Administrative8,574
Selling And Marketing Expenses2,803
Operating Expense18,44818,448
 
Net Interest Income (+$)
Interest Income2,341
Interest Expense-427
Other Finance Cost-3,977
Net Interest Income5,891
 
Pretax Income (+$)
Operating Income-15,501
Net Interest Income5,891
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,531-24,471
EBIT - interestExpense = -15,928
-6,531
-6,289
Interest Expense427
Earnings Before Interest and Taxes (EBIT)-15,501-6,104
Earnings Before Interest and Taxes (EBITDA)-14,198
 
After tax Income (+$)
Income Before Tax-6,531
Tax Provision-130
Net Income From Continuing Ops-12,430-6,661
Net Income-6,716
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses34,187
Total Other Income/Expenses Net8,970-5,891
 

Technical Analysis of Mediwound
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mediwound. The general trend of Mediwound is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mediwound's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mediwound Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 18.75.

The bearish price targets are: 13.68 > 13.59 > 13.57.

Tweet this
Mediwound Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mediwound Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mediwound Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mediwound Ltd. The current macd is 0.49718659.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mediwound price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Mediwound. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Mediwound price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Mediwound Ltd Daily Moving Average Convergence/Divergence (MACD) ChartMediwound Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mediwound Ltd. The current adx is 23.04.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Mediwound shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Mediwound Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mediwound Ltd. The current sar is 15.25.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Mediwound Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mediwound Ltd. The current rsi is 61.30. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Mediwound Ltd Daily Relative Strength Index (RSI) ChartMediwound Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mediwound Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mediwound price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Mediwound Ltd Daily Stochastic Oscillator ChartMediwound Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mediwound Ltd. The current cci is 120.86.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Mediwound Ltd Daily Commodity Channel Index (CCI) ChartMediwound Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mediwound Ltd. The current cmo is 26.30.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Mediwound Ltd Daily Chande Momentum Oscillator (CMO) ChartMediwound Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mediwound Ltd. The current willr is -27.61904762.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Mediwound is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Mediwound Ltd Daily Williams %R ChartMediwound Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Mediwound Ltd.

Mediwound Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mediwound Ltd. The current atr is 1.13373568.

Mediwound Ltd Daily Average True Range (ATR) ChartMediwound Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mediwound Ltd. The current obv is -232,169.

Mediwound Ltd Daily On-Balance Volume (OBV) ChartMediwound Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mediwound Ltd. The current mfi is 70.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Mediwound Ltd Daily Money Flow Index (MFI) ChartMediwound Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mediwound Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Mediwound Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mediwound Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.297
Ma 20Greater thanMa 5015.759
Ma 50Greater thanMa 10015.217
Ma 100Greater thanMa 20013.306
OpenGreater thanClose16.260
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Mediwound with someone you think should read this too:
  • Are you bullish or bearish on Mediwound? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mediwound? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mediwound Ltd

I send you an email if I find something interesting about Mediwound Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Mediwound Ltd.

Receive notifications about Mediwound Ltd in your mailbox!